How cognitive prejudices can influence research decisions, and how the pitfalls of human nature can be avoided
The Scientist
Most Recent
A male hormone-blocker currently used to treat prostate cancer may also benefit breast cancer patients.
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
Stress and inflammation Cardiovascular disease, including coronary artery disease and stroke, is the single greatest cause of death worldwide and is a major burden on health services and society. Most resources are currently directed towards surg
Fast blood flow protects against atherosclerosis: implications for treatment
The minority of Parkinson’s cases now known to have genetic origins are shedding light on the cellular mechanisms of all the rest, bringing researchers closer to a cause—and perhaps a cure.
What substance is supposed to have no effect but can make people feel better, has no chance for a big monetary payoff but is worth billions, and is used in virtually every rigorous clinical trial but has no single, universal formulation? The answer
As much as rainforests or deep-sea vents, the human gut holds rich stores of microbial chemicals that should be mined for their pharmacological potential.
The surprising results when drug development and altruism collide
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
